Could a simple supplement help dialysis patients need fewer sessions?

NCT ID NCT07699627

Not yet recruiting Disease control Sponsor: Centre Hospitalier le Mans Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study tests whether a supplement called Ketosteril, added to the usual diet, can help people who are starting hemodialysis (a treatment for kidney failure) stay on a less frequent schedule longer. The trial includes 70 adults beginning incremental hemodialysis, where sessions start at fewer than three times per week. Researchers will measure how many months patients can maintain this reduced schedule before needing full-dose dialysis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ketosteril (essential amino acids and ketoacids)
What this could lead to: If it works, this could help people starting dialysis delay the need for more frequent sessions, potentially improving quality of life.
What could go wrong: This is a small, early-phase trial (70 people) testing a supplement, so results may not be conclusive or widely applicable. The supplement may not extend the incremental phase or could cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INCREMENTAL HAEMODIALYSIS

Contacts and locations

Locations

Centre Hospitalier Le Mans

Le Mans, 72000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.